Pancreas Cancer Program Our goal is translating our research
into action for better patient care.As leaders in the
development of new techniques to target pancreatic cancer, our
physicians use what they learn in the lab to help treat
pancreatic cancer patients. Through the combination of extensive
research paired with clinical expertise, our experts have begun
the first human clinical trials to measure the effect of new
target drugs on the cancer stem cells that are in charge of the
growth and spread of pancreatic cancer. Pancreatic cancer is a
deadly disease characterized by: - late diagnosis - aggressive
invasion of surrounding tissues - early metastasis This type of
cancer has the worst prognosis of any major malignancy (5 year
survival rate is only 3%) and is the fourth most common cause of
cancer death. Recent advances in surgical and medical therapy
have had little impact on the mortality rate of this disease.
Pancreatic cancer is notoriously resistant to many types of
cytotoxic chemotherapy and ionizin